A new business model is needed to drive antibiotic development

June 14, 2016, Public Library of Science

The current business model for antibiotics is plagued by market failures and perverse incentives that both work against conservation efforts and provide insufficient rewards to drive the development of much-needed new treatments for resistant infection according to Kevin Outterson, from Boston University School of Law, Boston, US and Chatham House, UK, and colleagues in an Essay published in PLOS Medicine.

In their Essay the authors outline how a business model that delinks rewards from sales volume of an antibiotic could work. In addition they describe critical issues that need to be overcome to make this business model a reality so that could be developed and conserved to avoid the development of resistant bacteria.

The authors conclude, "[t]he UK's [Antimicrobial Resistance] Review, led by Lord Jim O'Neill, proposed that "a successful intervention must partially or fully 'de-link' profit from sales" ... With this growing focus on antibiotic delinkage, we see the need for a global conversation that applies delinkage principles to address access, conservation, and innovation of antibiotics in concert and not in isolation."

Explore further: A range of interventions could curb rising antibiotic resistance in India

More information: Outterson K, Gopinathan U, Clift C, So AD, Morel CM, R√łttingen J-A (2016) Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality. PLoS Med 13(6): e1002043. DOI: 10.1371/journal.pmed.1002043

Related Stories

A range of interventions could curb rising antibiotic resistance in India

March 2, 2016
Antibiotic resistance is a global public health threat and one of particular concern in India. A mix of poor public health systems, high rates of infectious disease, inexpensive antibiotics, and rising incomes are is coming ...

Special collection presents the state of science for evaluating antibiotic resistance in agroecosystems

March 3, 2016
The World Health Organization has identified antibiotic resistance as a serious threat to human health across the world. The Journal of Environmental Quality (JEQ) recently published a special section titled "Antibiotics ...

Answer to antibiotic-resistant infections could already be on the market

April 26, 2016
The rise of antibiotic resistant bacterial pathogens is an increasingly global threat to public health. In the United States alone antibiotic resistant bacterial pathogens kill thousands every year.

Deep changes urged to avoid mass deaths from superbugs

May 19, 2016
Ten million people could die by 2050 unless sweeping global changes are agreed to tackle increasing resistance to antibiotics, which can turn common ailments into killers, a report warned Thursday.

Recommended for you

New wave of complex street drugs puzzles emergency doctors

August 21, 2018
At a time when drug overdoses are becoming more prevalent and lethal, a new report provides a snapshot of regional illicit drug use and, for the first time, highlights the complexity of detecting and treating patients at ...

Study finds racial disparities in prescribing opioids for chronic pain

August 20, 2018
Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain. Black patients who receive opioids long-term are more likely than whites to be tested for illicit ...

Proposal seeks to improve assessment of drug risks

August 20, 2018
A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale (MCDHS), which informs drug policies across Europe. The changes focus on addressing use and abuse separately, collecting ...

US approves first generic competitor to Mylan's EpiPen

August 16, 2018
US regulators Thursday approved the first generic alternative for the EpiPen, a life-saving emergency allergy medicine, two years after soaring prices for the original version owned by Mylan stoked controversy.

Study: What patients really think about opioid vs non-opioid medications for chronic pain

August 14, 2018
Prescriptions of opioids for chronic pain has increased dramatically since the 1990s in spite of their known harms. Despite a shortage of scientific studies on the long-term effectiveness of opioids such as morphine, oxycodone ...

Doctors nudged by overdose letter prescribe fewer opioids

August 9, 2018
In a novel experiment, doctors got a letter from the medical examiner's office telling them of their patient's fatal overdose. The response: They started prescribing fewer opioids.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.